» Articles » PMID: 33710769

Plasma Hydrogen Sulfide: A Biomarker of Alzheimer's Disease and Related Dementias

Abstract

While heart disease remains a common cause of mortality, cerebrovascular disease also increases with age, and has been implicated in Alzheimer's disease and related dementias (ADRD). We have described hydrogen sulfide (H S), a signaling molecule important in vascular homeostasis, as a biomarker of cardiovascular disease. We hypothesize that plasma H S and its metabolites also relate to vascular and cognitive dysfunction in ADRD. We used analytical biochemical methods to measure plasma H S metabolites and MRI to evaluate indicators of microvascular disease in ADRD. Levels of total H S and specific metabolites were increased in ADRD versus controls. Cognition and microvascular disease indices were correlated with H S levels. Total plasma sulfide was the strongest indicator of ADRD, and partially drove the relationship between cognitive dysfunction and white matter lesion volume, an indicator of microvascular disease. Our findings show that H S is dysregulated in dementia, providing a potential biomarker for diagnosis and intervention.

Citing Articles

Navigating the dichotomy of reactive oxygen, nitrogen, and sulfur species: detection strategies and therapeutic interventions.

Baruah P, Padhi D, Moorthy H, Ramesh M, Govindaraju T RSC Chem Biol. 2025; 6(3):338-357.

PMID: 39877134 PMC: 11770382. DOI: 10.1039/d5cb00006h.


Sodium Thiosulfate: An Innovative Multi-Target Repurposed Treatment Strategy for Late-Onset Alzheimer's Disease.

Hayden M, Tyagi N Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770582 PMC: 11676759. DOI: 10.3390/ph17121741.


Essential role of sulfide oxidation in brain health and neurological disorders.

Kanemaru E, Ichinose F Pharmacol Ther. 2024; 266:108787.

PMID: 39719173 PMC: 11806942. DOI: 10.1016/j.pharmthera.2024.108787.


Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers.

Anjo S, He Z, Hussain Z, Farooq A, McIntyre A, Laughton C Antioxidants (Basel). 2024; 13(6).

PMID: 38929122 PMC: 11200609. DOI: 10.3390/antiox13060681.


Gut microbiota in combination with blood metabolites reveals characteristics of the disease cluster of coronary artery disease and cognitive impairment: a Mendelian randomization study.

Xu S, Liu Y, Wang Q, Liu F, Xian Y, Xu F Front Immunol. 2024; 14:1308002.

PMID: 38288114 PMC: 10822940. DOI: 10.3389/fimmu.2023.1308002.


References
1.
Jiang Z, Li C, Manuel M, Yuan S, Kevil C, McCarter K . Role of hydrogen sulfide in early blood-brain barrier disruption following transient focal cerebral ischemia. PLoS One. 2015; 10(2):e0117982. PMC: 4335059. DOI: 10.1371/journal.pone.0117982. View

2.
Kamoun P, Chabli A, Lallouchi K, Chadefaux-Vekemans B . Endogenous hydrogen sulfide overproduction in Down syndrome. Am J Med Genet A. 2002; 116A(3):310-1. DOI: 10.1002/ajmg.a.10847. View

3.
Abe K, Kimura H . The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996; 16(3):1066-71. PMC: 6578817. View

4.
He J, Li H, Yang L, Mao C . Role of hydrogen sulfide in cognitive deficits: Evidences and mechanisms. Eur J Pharmacol. 2019; 849:146-153. DOI: 10.1016/j.ejphar.2019.01.072. View

5.
Kalaria R, Akinyemi R, Ihara M . Does vascular pathology contribute to Alzheimer changes?. J Neurol Sci. 2012; 322(1-2):141-7. DOI: 10.1016/j.jns.2012.07.032. View